cell therapy

Life sciences lab
Jun 22, 2026

Report: NJ expands life sciences leadership

New Jersey expands its life sciences leadership with biotech growth, new biomanufacturing space and innovation investments.

BioNJ’s annual Dinner Meeting & Innovation Celebration
Feb 6, 2026

BioNJ dinner honors life sciences leaders, Sherrill keynotes

Gov. Mikie Sherrill delivered the keynote at the annual event, which highlighted awards, breakthroughs and industry innovators.

Cell Shuttles at Cellares' Bridgewater Smart Factory
Jan 29, 2026

Cellares raises $257M to scale automated cell therapy

The financing will help expand automated cell therapy manufacturing, funding global Smart Factories and boosting production for commercial use.

Cellares' Cell Q
Sep 17, 2025

Cellares expands Cell Q platform with new tech partners

The innovator with a base in Bridgewater is collaborating to advance its automated cell therapy QC platform, boosting throughput, compliance and data quality.

Made Scientific in Princeton
Aug 15, 2025

Made Scientific launches $12M cell therapy facility in NJ

The CDMO's 60,000-square-foot Princeton manufacturing site will boost GMP capacity and create more than 100 new jobs.

ProBio Cell & Gene Therapy Center of Excellence in Hopewell
Jul 1, 2025

ProBio opens cell, gene therapy hub in Hopewell

Located at the Princeton West Innovation Campus, the new 128,000-square-foot facility will create more than 110 high-skilled jobs.

French-based global health care company Pierre Fabre Laboratories celebrated its new office at 500 Plaza Drive in Secaucus on June 18, 2025.
Jun 30, 2025

Pierre Fabre USA makes in-state HQ move to Secaucus

Pierre Fabre Laboratories relocated its stateside base from Parsippany to expand its dermo-cosmetics, rare disease and oncology efforts while staying rooted in New Jersey.

Cellares' Kashiwa City facility rendering
Jun 30, 2025

Cellares expands global reach with cell therapy tech

The company is growing quickly in New Jersey and internationally with Smart Factories, an FDA designation and key partnerships to advance scalable, cost-effective cell therapy manufacturing.